Your browser doesn't support javascript.
loading
Does epicatechin contribute to the acute vascular function effects of dark chocolate? A randomized, crossover study.
Dower, James I; Geleijnse, Johanna M; Kroon, Paul A; Philo, Mark; Mensink, Marco; Kromhout, Daan; Hollman, Peter C H.
Afiliação
  • Dower JI; Top Institute Food and Nutrition, Wageningen, The Netherlands.
  • Geleijnse JM; Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
  • Kroon PA; Top Institute Food and Nutrition, Wageningen, The Netherlands.
  • Philo M; Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
  • Mensink M; Food and Health Programme, Institute of Food Research, Norwich Research Park, Norwich, UK.
  • Kromhout D; Food and Health Programme, Institute of Food Research, Norwich Research Park, Norwich, UK.
  • Hollman PC; Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
Mol Nutr Food Res ; 60(11): 2379-2386, 2016 11.
Article em En | MEDLINE | ID: mdl-27329037
ABSTRACT
SCOPE Cocoa, rich in flavan-3-ols, improves vascular function, but the contribution of specific flavan-3-ols is unknown. We compared the effects of pure epicatechin, a major cocoa flavan-3-ol, and chocolate. METHODS AND

RESULTS:

In a randomized crossover study, twenty healthy men (40-80 years) were supplemented with (1) 70g dark chocolate (150 mg epicatechin) with placebo capsules; (2) pure epicatechin capsules (2 × 50 mg epicatechin) with 75g white chocolate; and (3) placebo capsules with 75 g white chocolate (0 mg epicatechin). Vascular function (flow-mediated dilation (FMD) and augmentation index (AIx)) were measured before and 2 hours after interventions. Epicatechin metabolites time-profiles were measured in blood to calculate the bioavailability. Pure epicatechin did not significantly improve FMD (+0.75%; p = 0.10) or AIx (-2.2%; p = 0.23) compared to placebo. Dark chocolate significantly improved FMD (+0.96%; p = 0.04) and AIx (-4.6%; p = 0.02). Differences in improvements in FMD (+ 0.21%; p = 0.65) or Aix (-2.4%; p = 0.20) between pure epicatechin and dark chocolate were not significant. The bioavailability of epicatechin did not differ between pure epicatechin and dark chocolate (p = 0.14).

CONCLUSIONS:

Despite differences in epicatechin dose, improvements in vascular function after pure epicatechin and chocolate were similar and the bioavailability did not differ, suggesting a role for epicatechin.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cacau / Catequina / Chocolate Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cacau / Catequina / Chocolate Tipo de estudo: Clinical_trials Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article